Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab. Moiola L, Mandelli A, Tarkowski M, Finardi A, et al. J Neurol 2025;272:314.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moiola L, Mandelli A, Tarkowski M, Finardi A, et al. Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab. J Neurol 2025;272:314.
PMID: 40186086